Hepatocellular carcinoma in the thalassaemia syndromes

British Journal of Haematology

Volumn 124, Issue 1, 2004, Pages 114-117

  Borgna Pignatti, Caterina ^a   Vergine, Gianluca ^a   Lombardo, Turi ^b   Cappellini, Maria Domenica ^c   Cianciulli, Paolo ^d   Maggio, Aurelio ^e   Renda, Disma ^e   Lai, Maria Eliana ^f   Mandas, Antonella ^f   Forni, Gianluca ^g   Piga, Antonio ^h   Bisconte, Maria Grazia ⁱ  

^a UNIVERSITY OF FERRARA   (Italy)

^b Centro per la Thalassemia   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d S EUGENIO HOSPITAL   (Italy)

^e VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g GALLIERA HOSPITAL   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ Centro Studi della Microcitemia   (Italy)

Author keywords

Cirrhosis; Hepatitis C; Hepatocellular carcinoma; Iron overload; Thalassaemia

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; IRON OVERLOAD; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THALASSEMIA; VIRUS INFECTION;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS C; HUMANS; IRON OVERLOAD; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; THALASSEMIA;

EID: 9144224804     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04732.x     Document Type: Article

References (12)

1. Borgna-Pignatti, C., De Stefano, P., Sessa, F. & Avato, F. (1986) Hepatocellular carcinoma in thalassaemia major. Medical and Pediatric Oncology, 14, 327-328.
2. Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Piga, A., Di Gregorio, F., Gamberini, M.R., Sabato, V., Melevendi, C., Cappellini, M.D. & Verlato, G. (1998) Survival and disease complications in thalassemia major. Annals of the New York Academy of Sciences, 850, 227-231.
3. Bruix, J., Sherman, M., Llovet, J.M., Beaugrand, M., Lencioni, R., Burroughs, A.K., Christensen, E., Pagliaro, L., Colombo, M., Rodes, J. & EASL Panel of Experts on HCC (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. Journal of Hepatology, 35, 421-430.
4. Minola, E., Prati, D., Suter, F., Maggiolo, F., Caprioli, F., Sonzogni, A., Fraquelli, M,. Paggi, S. & Conte, D. (2002) Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood, 99, 4588-4591.
5. Modell, B., Khan, M. & Darlison, M. (2000) Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet, 355, 2051-2052.
6. Niederau, C., Fischer, R., Purschel, A., Stremmel, W., Haussinger, D. & Strohmeyer, G. (1996) Long-term survival in patients with hereditary hemochromatosis. Gastroenterology, 110, 1107-1119.
7. Nishiguchi, S., Kuroki, T., Nakatani, S., Morimoto, H., Takeda, T., Nakajima, S., Shiomi, S., Seki, S., Kobayashi, K. & Otani, S. (1995) Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet, 346, 1051-1055.
8. Prati, D. (2000) Benefits and complications of regular blood transfusion in patients with beta-thalassemia major. Vox Sanguinis, 79, 129-137.
9. Ryder, S.D. for the British Society of Gastroenterology. (2003) Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut, 52 (Suppl 3), iii1-8.
10. Tong, M.J., el-Farra, N.S., Reikes, A.R. & Co, R.L. (1995) Clinical outcomes after transfusion-associated hepatitis C. New England Journal of Medicine, 332, 1463-1466.
11. Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H. & Kawashima, T. (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. New England Journal of Medicine, 328, 1797-1801.
12. Wonke, B., Hoffbrand, A.V., Brown, D. & Dusheiko, G. (1990) Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major. Journal of Clinical Pathology, 43, 638-640.